Navigation Links
Rensselaer researcher wins prestigious American Cancer Society award for work on cancer
Date:10/14/2010

Troy, N.Y. A recent Research Scholar Grant from the American Cancer Society acknowledges the potential of Rensselaer researcher Lee Ligon's work on breast cancer. Ligon is investigating interactions between cells as breast cancer spreads within the body.

"We're trying to figure out how cancerous and non-cancerous cells communicate with each other, how they bind to each other, and what the consequences of those interactions are," Ligon said.

The Research Scholar Grant from the American Cancer Society includes a four-year $720,000 award to support this research.

"The Research Scholar Grant is a highly prestigious award for junior faculty. This grant acknowledges the importance of Dr. Ligon's work in the field of cancer research and heralds a promising future of valuable insights and discoveries," said Susan Gilbert, a Rensselaer professor and head of the department of biology.

Ligon studies cadherins, proteins that cause cells to adhere to one another, allowing cells to form organs and other structures. Different cadherins are expressed by different cells, each for its proper function.

"Cells have to stick together appropriately and if they express the same cadherin they will," Ligon said. "But that only works in the normal situation when cells are sticking to cells that they're supposed to stick to. We're interested in the situation in tumors."

More than 90 percent of all cancers, Ligon said, originate in epithelial cells cells that form barriers between the inside and outside of the body, like skin cells, or the cells that line the intestines, or milk ducts in the breasts.

Because epithelial cells form a barrier between the inside and outside of the body, they must renew themselves more frequently than many other kinds of cells like muscle or nerve cells. That presents more opportunity for abnormal cell division and cancer.

Most breast cancers originate in the epithelial cells that line milk ducts. In the early stages of the disease, the epithelial cells begin to grow abnormally, but are still confined within the lining of the milk ducts. At that point, the cancerous growth can still be excised with a surgeon's knife.

But with continued growth, the cancerous cells break through the barrier between the lining and the surrounding tissue the stroma at which point they come into contact with a different type of cell called fibroblasts. Now the cancer is progressing into the body. Unchecked, it will reach the bloodstream at which point it becomes far more difficult to treat.

"Normally fibroblasts live in stroma, epithelial cells live in ducts, and they never make physical contact. They don't come into contact with one another until there is pathological situation cancerous cells have broken the membrane, and invaded the stroma," Ligon said. "When that happens, they run into each other and we don't know much about the consequences of that contact between epithelial cells and fibroblasts."

In an earlier study, Ligon found that cancerous epithelial cells and fibroblasts do adhere to one another, despite expressing different cadherins.

"Everyone thought they wouldn't stick together, but when we introduced mildly invasive cancerous epithelial cells to normal fibroblasts, a certain percentage stick together," Ligon said.

"What we don't know is whether that will happen with normal epithelial cells or more invasive cancerous epithelial cells and fibroblasts," Ligon said. Those questions will form the basis for her next series of experiments, in which Ligon will introduce cancerous epithelial cells of varying invasiveness to healthy fibroblasts and observe the outcome.

Ligon said the results of her experiments could shed light on another puzzle: Whether her early results in which the cancerous epithelial cells and healthy fibroblasts did adhere bode ill or good for the patient.

"It is possible that this adhesion to these local cells is a good thing, in that it may be a barrier to stop metastasis. It's also possible that it will cause these cells to be more invasive," Ligon said.


'/>"/>

Contact: Mary Martialay
martim12@rpi.edu
518-276-2146
Rensselaer Polytechnic Institute
Source:Eurekalert

Related biology news :

1. Rensselaer professors Dordick and Interrante named ACS Fellows
2. Purifying proteins: Rensselaer researchers use NMR to improve drug development
3. Rensselaer professor uncovers mysterious workings of cholera bacteria
4. Left or right? Early clues to soccer penalty kicks revealed at Rensselaer Polytechnic Institute
5. Rensselaer Polytechnic Institute professor Peter M. Tessier named Pew Scholar
6. Rensselaer Polytechnic Institute professor Patrick Underhill receives NSF CAREER award
7. Rensselaer Polytechnic Institute wins $2.45 million grant to support stem cell research
8. Rensselaer researchers to send bacteria into orbit aboard space shuttle Atlantis
9. Rensselaer leads effort to replace 1 of the most widely used drugs in American hospitals
10. Rensselaer receives more than $2 million from New York State to fund stem cell research
11. Trustee makes donation to start new solar energy research center at Rensselaer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/9/2016)... -- Aware, Inc. (NASDAQ: AWRE ), a leading supplier of ... quarter and year ended December 31, 2015.  ... 2015 was $6.9 million, an increase of 61% compared to $4.3 ... fourth quarter of 2015 was $2.6 million compared to $0.2 million ... --> Higher revenue and operating income in the ...
(Date:2/3/2016)... 4, 2016 --> --> ... M (105.0), up 1,187% compared with fourth quarter of 2014. ... 517.6 M (loss: 30.0). Earnings per share increased to SEK ... 537.4 M (neg: 74.7). , --> ... to SEK 2,900.5 M (233.6), up 1,142% compared with 2014. ...
(Date:2/2/2016)... This BCC Research report provides a ... the recent advances in high throughput ‘omic platforms ... forward. Includes forecast through 2019. Use ... opportunities that exist in the bioinformatic market. Analyze ... well as IT and bioinformatics service providers. Analyze ...
Breaking Biology News(10 mins):
(Date:2/11/2016)... Inc. (NASDAQ: NBIX ) today announced its financial results for ... --> --> For the fourth quarter of ... $0.34 loss per share, compared to a net loss of $19.4 ... 2014. For the year ended December 31, 2015, the Company reported ... as compared to a net loss of $60.5 million, or $0.81 ...
(Date:2/11/2016)... International, a not-for-profit organization focused on the ethics and governance ... to patients around the world, today announced that the editors ... the Good Pharma Scorecard an ,Editors, Pick, ... of BMJ Open ,s ,Most Popular Articles, which includes ... read. Ed Sucksmith , assistant editor of ...
(Date:2/11/2016)... ... February 11, 2016 , ... ... information focused on the development and manufacture of biopharmaceuticals and therapeutics, announces ... of the 2016 BioProcess International Awards – Recognizing Excellence in the People, ...
(Date:2/11/2016)... --  BioInformant announces the February 2016 release of ... Tools, and Technologies – Market Size, Segments, Trends, and ... The first and only market research ... has more than a decade of historical information on ... cell type. This powerful 175 page global strategic report ...
Breaking Biology Technology: